Towards the Therapeutic Use of Thrombospondin 1/CD47 Targeting TAX2 Peptide as an Antithrombotic Agent.
- DOI
- 10.1161/atvbaha.120.314571
- Published
- 2021 Jan
- Container
- Arteriosclerosis, thrombosis, and vascular biology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1161/atvbaha.120.314571,
title = {Towards the Therapeutic Use of Thrombospondin 1/CD47 Targeting TAX2 Peptide as an Antithrombotic Agent.},
author = {Jeanne A and Sarazin T and Charlé M and Kawecki C and Kauskot A and Hedtke T and Schmelzer CEH and Martiny L and Maurice P and Dedieu S},
year = {2021},
journal = {Arteriosclerosis, thrombosis, and vascular biology},
doi = {10.1161/atvbaha.120.314571},
url = {https://doi.org/10.1161/atvbaha.120.314571}
}RIS
TY - JOUR TI - Towards the Therapeutic Use of Thrombospondin 1/CD47 Targeting TAX2 Peptide as an Antithrombotic Agent. AU - Jeanne A AU - Sarazin T AU - Charlé M AU - Kawecki C AU - Kauskot A AU - Hedtke T AU - Schmelzer CEH AU - Martiny L AU - Maurice P AU - Dedieu S PY - 2021 JO - Arteriosclerosis, thrombosis, and vascular biology DO - 10.1161/atvbaha.120.314571 UR - https://doi.org/10.1161/atvbaha.120.314571 ER -
APA
A, J., T, S., M, C., C, K., A, K., T, H., CEH, S., L, M., P, M., & S, D. (2021). Towards the Therapeutic Use of Thrombospondin 1/CD47 Targeting TAX2 Peptide as an Antithrombotic Agent.. Arteriosclerosis, thrombosis, and vascular biology. https://doi.org/10.1161/atvbaha.120.314571
Source records
- pubmed · retrieved 2026-09-26T12:00:28.111Z